1. Polypeptide N-Acetylgalactosaminyltransferase 14 (GALNT14) as a Chemosensitivity-Related Biomarker for Osteosarcoma
   Qiong Xi et al, 2023, Journal of Oncology CrossRef
2. Rs9679162 genotype predicts prognosis of real-world advanced hepatocellular carcinoma treated by sorafenib
   Chih-Lang Lin et al, 2023, Cancer Biomarkers CrossRef
3. An SNP Marker Predicts Colorectal Cancer Outcomes with 5-Fluorouracil-Based Adjuvant Chemotherapy Post-Resection
   Hao Chien et al, 2024, International Journal of Molecular Sciences CrossRef
4. The GALNT14 Genotype Predicts Postoperative Outcome of Pancreatic Ductal Adenocarcinoma
   Chun-Cheng Chiang et al, 2019, Journal of Clinical Medicine CrossRef
5. Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
   Kung-Hao Liang et al, 2021, Biomedicines CrossRef
6. The Search for Risk, Diagnostic, and Prognostic Biomarkers of Cholangiocarcinoma and Their Biological and Clinicopathologic Significance
   Rocio I.R. Macias et al, 2024, The American Journal of Pathology CrossRef
7. EFEMP2 Mediates GALNT14-Dependent Breast Cancer Cell Invasion
   Tao Zuo et al, 2018, Translational Oncology CrossRef
8. Genomic Analysis Identifies New Loci Associated With Motor Complications in Parkinson's Disease
   Ho-Sung Ryu et al, 2020, Frontiers in Neurology CrossRef
9. A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy
   Chen-Chun Lin et al, 2020, The Pharmacogenomics Journal CrossRef
10. The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review
    Guanwu Wang et al, 2022, Cancers CrossRef
11. GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers
    Wey-Ran Lin et al, 2020, International Journal of Molecular Sciences CrossRef